Yahoo Finance • 27 days ago
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. [topmovers] GAINERS TICKER CHANGE COMMENT GCTK [ht... Full story
Yahoo Finance • 2 months ago
Investing.com -- Entero Therapeutics Inc (NASDAQ:ENTO) stock fell 5.7% after the clinical-stage biopharmaceutical company announced plans for a 1-for-3 reverse stock split to regain Nasdaq compliance. The company, which specializes in dev... Full story
Yahoo Finance • 2 months ago
Curious about what's happening in today's session? Check out the latest stock movements and price changes. [topmovers] GAINERS TICKER CHANGE COMMENT EQ [https://www.chartmill.com/stock/quote/EQ/profile] 77.82% Positive ma... Full story
Yahoo Finance • 2 months ago
Here are the top movers in Monday's session, showcasing the stocks with significant price changes. [topmovers] GAINERS TICKER CHANGE COMMENT EQ [https://www.chartmill.com/stock/quote/EQ/profile] 87.56% With a 87.56% surge... Full story
Yahoo Finance • 2 months ago
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Wang & Lee Group Inc. 319,475,864 0.069 0.0559 0.0592 +0.0134 Entero The... Full story
Yahoo Finance • 2 months ago
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs. [gap] TODAY'S GAP UP STOCKS TICKER CHANGE COMMENT ENTO [https://www.chartmill.com/stock/quote/ENTO/p... Full story
Yahoo Finance • 2 months ago
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT E... Full story
Yahoo Finance • 2 months ago
BOCA RATON - Entero Therapeutics, Inc. (NASDAQ:ENTO), currently valued at $1.74 million and showing a -14% return over the past week according to InvestingPro, has secured approximately $3 million through private placement agreements with... Full story
Yahoo Finance • 3 months ago
Entero Therapeutics, Inc. (NASDAQ:ENTO), currently trading at $0.53 with a market capitalization of $2.57 million, announced Tuesday that it has regained compliance with Nasdaq Listing Rule 5620(a) following the successful holding of its a... Full story
Yahoo Finance • 3 months ago
Entero Therapeutics, Inc. (NASDAQ:ENTO) announced Monday that it has received an extension from the Nasdaq Stock Market to regain compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Mark... Full story
Yahoo Finance • 8 months ago
BOCA RATON, Fla., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for... Full story
Yahoo Finance • 8 months ago
BOCA RATON, Fla., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (Nasdaq: ENTO) (“Entero” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for... Full story